New hope for stubborn high cholesterol: experimental drug SHR-1918 enters trials
NCT ID NCT07404553
First seen Feb 12, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This study tests an experimental drug called SHR-1918 for people with high cholesterol that remains high despite taking statins and PCSK9 inhibitors. About 126 adults will receive either SHR-1918 or a placebo to see if the drug safely lowers cholesterol levels over 12 to 24 weeks. The goal is to offer a new option for controlling cholesterol and reducing heart disease risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.